Indication

Punctate epithelial keratopathy

Punctate epithelial keratopathy is an ocular surface disorder marked by multifocal, pinpoint cellular disruption, degeneration, or loss within the corneal epithelium. Read more about Punctate epithelial keratopathy

26 drugs 17 manufacturers

Advertisement

Drugs that treat it

Common Punctate epithelial keratopathy therapies.

Showing 10–18 of 26 drugs

Filter & compare in the drug finder →Opens the drug finder with Punctate epithelial keratopathy preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Punctate epithelial keratopathy.

Punctate epithelial keratopathy is an ocular surface disorder marked by multifocal, pinpoint cellular disruption, degeneration, or loss within the corneal epithelium.

Commonly occurring secondary to conditions such as dry eye disease, ocular surface toxicity, contact lens overwear, exposure, or viral infections, it primarily affects the anterior segment of the eye across diverse patient populations.

Pathophysiologically, localized micro-epithelial breakdown compromises the corneal barrier, leading to characteristic fine, discrete lesions visible on slit-lamp biomicroscopy that readily take up diagnostic dyes such as sodium fluorescein.

Clinically, affected patients typically present with ocular irritation, foreign body sensation, photophobia, excessive tearing, and intermittent visual blurring.

Personalize your experience

Follow Punctate epithelial keratopathy and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it